BIIB Stock-Based Compensation

Biogen · Stock-Based Compensation

BIIB logo

BIIB Stock-Based Compensation

Latest reported$134.90M
BIIB TTM Stock-Based Comp ($0.00 → $134.90M)
High-resolution chart · PNG

BIIB stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
134,900,000
293,800,000
290,800,000
306,300,000
303,700,000
299,400,000
291,200,000
271,000,000
260,500,000
263,600,000
266,400,000
278,700,000
280,100,000
262,100,000
254,100,000
245,700,000
237,800,000
236,200,000
238,600,000
228,800,000
210,800,000
200,700,000
198,400,000
187,800,000
196,000,000
204,300,000
182,300,000
182,400,000
173,800,000
159,800,000
157,500,000
149,600,000
142,400,000
138,100,000
131,700,000
138,100,000
141,700,000
146,500,000
154,800,000
147,663,000
151,763,000
154,563,000
161,363,000
187,800,000
185,652,000
181,568,000
175,808,000
150,950,000
152,762,000
145,876,000
136,293,000
135,039,000
125,486,000
122,927,000
118,566,000
114,758,000
116,073,000
112,282,000
113,005,000
119,857,000
129,855,000
149,939,000
167,826,000
175,594,000
177,380,000
174,019,000
160,902,000
161,770,000
157,452,000
149,567,000
146,207,000
136,259,000
131,357,000
128,098,000
123,129,000
115,933,000
120,577,000
132,723,000
126,783,000
120,739,000
87,221,000
53,994,000
38,225,000
36,340,000
37,221,000
33,070,000
25,219,000
8,424,000
4,627,000
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.